Elanco makes medicines for pets and farm animals.
Elanco Animal Health Incorporated (ELAN) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 06:29 ET. Consensus EPS estimate is $0.20.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | FY2026 Q2 | $0.27 | $0.34 | +26.3% | $1.37B |
| 2026-05-06 | FY2026 Q1 | $0.35 | $0.40 | +15.7% | $1.37B |
| 2026-02-24 | FY2025 Q4 | $0.11 | $0.13 | +18.2% | $1.14B |
| 2025-11-05 | FY2025 Q3 | $0.13 | $0.19 | +46.2% | $1.14B |
| 2025-08-07 | FY2025 Q2 | $0.20 | $0.26 | +30.0% | $1.24B |
| 2025-05-07 | FY2025 Q1 | $0.31 | $0.37 | +19.4% | $1.19B |
| 2025-02-25 | FY2024 Q4 | $0.16 | $0.14 | -12.5% | $1.02B |
| 2024-08-08 | FY2024 Q2 | $0.24 | $0.30 | +25.0% | $1.18B |
ELAN has beaten consensus EPS in 7 of its last 8 reported quarters.
ELAN reported Aug 5. The highlights: EPS of $0.34 — a big beat vs the $0.27 estimate (+26%); revenue of $1.37B — a beat vs the $1.31B consensus (+4%). Focus now shifts to pet products and farm-animal trends.
See ELAN on the live calendar →